Simplex Trading
VYGR icon

Simplex Trading’s Voyager Therapeutics VYGR Stock Holding History

Simplex Trading’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$85.9K Buy
22,261
+14,126
+174% +$55.6K ﹤0.01% 5271
2025
Q4 		$32K Buy
+8,135
New +$36K ﹤0.01% 6057
2025
Q3 		– Sell
-280
Closed -$1.01K – 10188
2025
Q2 		$0 Sell
280
-2,413
-90% -$7.78K ﹤0.01% 9848
2025
Q1 		$9K Sell
2,693
-7,381
-73% -$34.5K ﹤0.01% 7204
2024
Q4 		$57K Buy
10,074
+7,170
+247% +$46.2K ﹤0.01% 5753
2024
Q3 		$16K Sell
2,904
-1,068
-27% -$7.76K ﹤0.01% 6860
2024
Q2 		$31K Sell
3,972
-7,639
-66% -$64K ﹤0.01% 6548
2024
Q1 		$108K Buy
+11,611
New +$98K ﹤0.01% 5502
2023
Q4 		– Sell
-7,572
Closed -$54.9K – 9949
2023
Q3 		$58K Buy
+7,572
New +$69.1K ﹤0.01% 5671
2023
Q2 		– Sell
-16,623
Closed -$172K – 10059
2023
Q1 		$128K Buy
+16,623
New +$132K ﹤0.01% 4878
2021
Q4 		– Sell
-724
Closed -$2.47K – 11557
2021
Q3 		$2K Buy
+724
New +$2.35K ﹤0.01% 9575
2021
Q2 		– Sell
-2,642
Closed -$12K – 10777
2021
Q1 		$12K Buy
+2,642
New +$18K ﹤0.01% 7813
2020
Q4 		– Sell
-1,465
Closed -$14.1K – 9164
2020
Q3 		$15K Buy
1,465
+355
+32% +$4.17K ﹤0.01% 6580
2020
Q2 		$14K Sell
1,110
-985
-47% -$11.5K ﹤0.01% 6465
2020
Q1 		$19K Sell
2,095
-8,503
-80% -$97.6K ﹤0.01% 6011
2019
Q4 		$147K Buy
10,598
+4,099
+63% +$59.6K ﹤0.01% 4087
2019
Q3 		$111K Sell
6,499
-17,398
-73% -$365K ﹤0.01% 4215
2019
Q2 		$650K Buy
23,897
+7,881
+49% +$180K ﹤0.01% 2332
2019
Q1 		$306K Buy
16,016
+15,918
+16,243% +$207K ﹤0.01% 3179
2018
Q4 		$0 Sell
98
-289
-75% -$3.71K ﹤0.01% 7908
2018
Q3 		$7K Buy
387
+114
+42% +$2.19K ﹤0.01% 6624
2018
Q2 		$5K Sell
273
-100
-27% -$1.98K ﹤0.01% 6736
2018
Q1 		$7K Sell
373
-12,143
-97% -$262K ﹤0.01% 4383
2017
Q4 		$207K Buy
12,516
+12,110
+2,983% +$208K 0.01% 1246
2017
Q3 		$8K Buy
+406
New +$4.58K ﹤0.01% 4019

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Simplex Trading's VYGR Position: Q1 2026 in Review

Simplex Trading increased its Voyager Therapeutics (VYGR) stake by 174% in Q1 2026, buying an estimated $55.6K and bringing the position to 22,261 shares worth $85.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5271.

Simplex Trading first reported a position in VYGR in Q3 2017 and has held it in 25 quarters since. The position peaked at $650K in Q2 2019. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • Simplex Trading held 22,261 shares of Voyager Therapeutics worth $85.9K as of Q1 2026.
  • Simplex Trading bought 14,126 Voyager Therapeutics shares in Q1 2026, an estimated $55.6K.
  • Voyager Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5271 holding.
  • Simplex Trading first reported a position in Voyager Therapeutics in Q3 2017 and has held it in 25 quarters since.
  • Simplex Trading's Voyager Therapeutics position peaked at $650K in Q2 2019.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.